Systemic absorption of lidocaine after topical application for the treatment of oral mucositis in bone marrow transplantation patients - PubMed (original) (raw)
Systemic absorption of lidocaine after topical application for the treatment of oral mucositis in bone marrow transplantation patients
S Elad et al. J Oral Pathol Med. 1999 Apr.
Abstract
This paper evaluates lidocaine absorption via oral mucosa following its topical application for symptomatic treatment of bone marrow transplantation (BMT)-induced oral mucositis. Five patients with high-grade oral mucositis after allogeneic BMT were entered consecutively into the study. Five healthy individuals served as controls. All 10 participants rinsed their mouth with 5 ml of a 2% lidocaine solution for 1 min, after which they expectorated the liquid. Blood samples were drawn at 1, 5, 10, 20, 30 and 60 min after rinsing and centrifuged. Plasma lidocaine levels were measured by fluorescence polarization immunoassay. In the BMT patients, plasma lidocaine levels were lower than the therapeutic range of this drug (0.2 microg/ml vs 1.5-5.5 microg/ml), while in the controls no detectable lidocaine levels were noted. The data from this preliminary study indicate that lidocaine prescribed as an anesthetic mouthwash in BMT patients with oral mucositis results in minor systemic absorption of the drug.
Similar articles
- The use of tretinoin as oral mucositis prophylaxis in bone marrow transplantation patients: a preliminary study.
Cohen G, Elad S, Or R, Galili D, Garfunkel AA. Cohen G, et al. Oral Dis. 1997 Dec;3(4):243-6. doi: 10.1111/j.1601-0825.1997.tb00049.x. Oral Dis. 1997. PMID: 9643220 Clinical Trial. - Pharmacokinetics of EMLA cream 5% application to oral mucosa.
Vickers ER, Marzbani N, Gerzina TM, McLean C, Punnia-Moorthy A, Mather L. Vickers ER, et al. Anesth Prog. 1997 Winter;44(1):32-7. Anesth Prog. 1997. PMID: 9481979 Free PMC article. - Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation.
Anderson PM, Ramsay NK, Shu XO, Rydholm N, Rogosheske J, Nicklow R, Weisdorf DJ, Skubitz KM. Anderson PM, et al. Bone Marrow Transplant. 1998 Aug;22(4):339-44. doi: 10.1038/sj.bmt.1701317. Bone Marrow Transplant. 1998. PMID: 9722068 Clinical Trial. - Oral mucositis in myelosuppressive cancer therapy.
Epstein JB, Schubert MM. Epstein JB, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Sep;88(3):273-6. doi: 10.1016/s1079-2104(99)70026-0. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999. PMID: 10503852 Review. - The role of herpes simplex virus in the development of oral mucositis in bone marrow transplant recipients.
Woo SB, Sonis ST, Sonis AL. Woo SB, et al. Cancer. 1990 Dec 1;66(11):2375-9. doi: 10.1002/1097-0142(19901201)66:11<2375::aid-cncr2820661121>3.0.co;2-6. Cancer. 1990. PMID: 2173971 Review.
Cited by
- Oral Chronic Graft-Versus-Host Disease.
Dean D, Sroussi H. Dean D, et al. Front Oral Health. 2022 May 20;3:903154. doi: 10.3389/froh.2022.903154. eCollection 2022. Front Oral Health. 2022. PMID: 35719318 Free PMC article. Review. - Pharmacokinetics of lidocaine delivered from a transmucosal patch in children.
Leopold A, Wilson S, Weaver JS, Moursi AM. Leopold A, et al. Anesth Prog. 2002 Summer;49(3):82-7. Anesth Prog. 2002. PMID: 15384296 Free PMC article. - Central nervous system toxicity following topical skin application of lidocaine.
Brosh-Nissimov T, Ingbir M, Weintal I, Fried M, Porat R. Brosh-Nissimov T, et al. Eur J Clin Pharmacol. 2004 Nov;60(9):683-4. doi: 10.1007/s00228-004-0814-4. Epub 2004 Oct 2. Eur J Clin Pharmacol. 2004. PMID: 15568142 No abstract available. - MASCC/ISOO clinical practice statement: Current understanding on controversies in basic oral care in hemato-oncology and hematopoietic cell transplantation.
Raber-Durlacher JE, Zadik Y, Treister NS, Stempler N, Bruno JS, Epstein JB, Elad S. Raber-Durlacher JE, et al. Support Care Cancer. 2024 Jul 25;32(8):550. doi: 10.1007/s00520-024-08690-1. Support Care Cancer. 2024. PMID: 39048882 Free PMC article. - Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD.
Meier JK, Wolff D, Pavletic S, Greinix H, Gosau M, Bertz H, Lee SJ, Lawitschka A, Elad S; International Consensus Conference on Clinical Practice in cGVHD. Meier JK, et al. Clin Oral Investig. 2011 Apr;15(2):127-39. doi: 10.1007/s00784-010-0450-6. Epub 2010 Sep 22. Clin Oral Investig. 2011. PMID: 20859645
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical